Prescription medicine
Flurandrenolide Brand names: Cordran
Flurandrenolide (Cordran) is a prescription medicine with an FDA approval on record since 1963. FDA's NDC Directory lists it from 2 generic labelers, and pharmacies paid $1.16 per mL (Flurandrenolide 0.05% lotion) in the October 7, 2026 NADAC survey.
- Generic listed
Check it at the source: the flurandrenolide FDA label on DailyMed (effective October 11, 2022, Padagis Israel Pharmaceuticals Ltd); the NDA 13790 record on Drugs@FDA; every flurandrenolide label on DailyMed.
Highlights of the record
FDA label of October 11, 2022; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageFlurandrenolide Lotion USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Forms and strengths
- 0.5 mg/ml
- 0.5 mg/g
Lotion; cream; tape.
On the market
- Earliest approval on file
- March 19, 1963 Cordran, Ina Pharms; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- 5 first April 29, 1982; 2 with a marketed status in Drugs@FDA
- Labelers listed (NDC)
- 4 of which 2 under generic applications, 2 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $1.16 per mL Flurandrenolide 0.05% lotion
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- 1 since 2021 0 Class I among all firms' recalls; latest April 9, 2021
- FAERS reports
- 329 through July 30, 2026
What is flurandrenolide used for?
From the label: indications and usageFlurandrenolide Lotion USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
FDA pharmacologic class: Corticosteroid.
Source: FDA drug label (Flurandrenolide), Padagis Israel Pharmaceuticals Ltd, effective October 11, 2022 (SPL set 9c4f5aea-2e08-400c-88f6-d9e3013afda7), via openFDA; the full label on DailyMed
Is there a generic for flurandrenolide (Cordran)?
The FDA approved the first generic flurandrenolide on April 29, 1982. 5 generic applications are approved; 2 of them carry a current (not discontinued) marketing status in Drugs@FDA; that status is not evidence that the generic is on sale.
FDA's NDC Directory lists flurandrenolide from 2 labelers under a generic (ANDA) application and from 2 brand labelers. A listing means the company has registered the product for sale; it does not show that every pharmacy stocks it.
- 1963 earliest approval on file
- 1982 first generic approved
- red ticks recalls
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for flurandrenolide (Cordran)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $1.16 per mL (Flurandrenolide 0.05% lotion), up 2% from $1.13 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Flurandrenolide 0.05% lotion (generic)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Flurandrenolide 0.05% lotion | Generic | $1.16 per mL | n/a | +2% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
Has flurandrenolide been recalled?
The FDA's Enforcement Report lists 1 recall naming flurandrenolide since 2021: 0 Class I (the most serious), 1 Class II, 0 Class III; 1 still ongoing. A recall names products and lots, not every product of the medicine.
| Started | Class | Company | Reason |
|---|---|---|---|
| April 9, 2021 | Class II | Teligent Pharma, Inc. | Failed Impurities/Degradation Specifications: |
Source: FDA Enforcement Report (drug recalls) via openFDA, through October 8, 2026
What do FAERS reports show for flurandrenolide?
The FDA Adverse Event Reporting System holds 329 reports that list flurandrenolide among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 6 are coded as a death and 40 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other corticosteroids
- the pharmacologic class, with prices and generics
- Flurandrenolide side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other